OPEN ACCESS pISSN 2234-3806
eISSN 2234-3814

Cited by CrossRef (36)

  1. Nobuharu Tamaki, Masayuki Kurosaki, Yuka Takahashi, Yoshie Itakura, Sakura Kirino, Kento Inada, Koji Yamashita, Shuhei Sekiguchi, Yuka Hayakawa, Leona Osawa, Mayu Higuchi, Kenta Takaura, Chiaki Maeyashiki, Shun Kaneko, Yutaka Yasui, Kaoru Tsuchiya, Hiroyuki Nakanishi, Jun Itakura, Rohit Loomba, Namiki Izumi. Wisteria floribunda Agglutinin-Positive Mac-2 Binding Protein as a Screening Tool for Significant Liver Fibrosis in Health Checkup. IJMS 2020;22:40
    https://doi.org/10.3390/ijms22010040
  2. Amr Shaaban Hanafy, Khalid Ali Muftah Abdelaziz, Fedaa Nabil Mohammad, Amr Samir Ibrahim. Mac-2 binding protein glycosylation isomer as a potential biomarker of hepatocellular carcinoma in HCV-cured patients. Egypt Liver Journal 2024;14
    https://doi.org/10.1186/s43066-024-00389-6
  3. I-Cheng Lee, Hao-Jan Lei, Lei-Chi Wang, Yi-Chen Yeh, Gar-Yang Chau, Cheng-Yuan Hsia, Shu-Cheng Chou, Jiing-Chyuan Luo, Ming-Chih Hou, Yi-Hsiang Huang. M2BPGi Correlated with Immunological Biomarkers and Further Stratified Recurrence Risk in Patients with Hepatocellular Carcinoma. Liver Cancer 2024:1
    https://doi.org/10.1159/000540802
  4. Nobuharu Tamaki, Masayuki Kurosaki, Sakura Kirino, Namiki Izumi. Diagnostic accuracy of hepatocellular carcinoma risk prediction models during antiviral therapy in chronic hepatitis B patients. Hepatology Research 2021;51:1170
    https://doi.org/10.1111/hepr.13684
  5. Hideo Ohuchi, Ryotaro Asano, Aki Mori, Tomohiko Ishibashi, Daisuke Motooka, Michikazu Nakai, Yoshikazu Nakaoka. Gut Dysbiosis in Patients With Fontan Circulation. JAHA 2024;13
    https://doi.org/10.1161/JAHA.124.034538
  6. Se Young Jang, Won Young Tak, Soo Young Park, Young-Oh Kweon, Yu Rim Lee, Gyeonghwa Kim, Keun Hur, Man-Hoon Han, Won Kee Lee. Diagnostic Efficacy of Serum Mac-2 Binding Protein Glycosylation Isomer and Other Markers for Liver Fibrosis in Non-Alcoholic Fatty Liver Diseases. Ann Lab Med 2021;41:302
    https://doi.org/10.3343/alm.2021.41.3.302
  7. Sven M. Francque. Biomarkers for Liver Fibrosis Post–Liver Transplantation: Not As Easy As It Looks. Liver Transpl. 2021;27:327
    https://doi.org/10.1002/lt.25927
  8. Chien-Hung Chen, Tsung-Hui Hu, Jing-Houng Wang, Hsueh-Chou Lai, Chao-Hung Hung, Sheng-Nan Lu, Cheng-Yuan Peng. A Mac-2 Binding Protein Glycosylation Isomer-Based Risk Model Predicts Hepatocellular Carcinoma in HBV-Related Cirrhotic Patients on Antiviral Therapy. Cancers 2022;14:5063
    https://doi.org/10.3390/cancers14205063
  9. Yu‐Ming Cheng, Chia‐Chi Wang. Comparison of Mac‐2 binding protein glycosylation isomer (M2BPGi) with AST to platelet ratio index (APRI), fibrosis 4 Score (FIB‐4), and nonalcoholic fatty liver disease (NAFLD) fibrosis score (NFS) for NAFLD patients. Adv in Digestive Medicine 2023;10:87
    https://doi.org/10.1002/aid2.13315
  10. Sakura Kirino, Nobuharu Tamaki, Masayuki Kurosaki, Kento Inada, Koji Yamashita, Shuhei Sekiguchi, Yuka Hayakawa, Leona Osawa, Mayu Higuchi, Kenta Takaura, Chiaki Maeyashiki, Shun Kaneko, Yutaka Yasui, Kaoru Tsuchiya, Hiroyuki Nakanishi, Jun Itakura, Yuka Takahashi, Namiki Izumi. Dynamic evaluation of hepatocellular carcinoma prediction models in patients with chronic hepatitis B receiving nucleotide/nucleoside analogue treatment. Journal of Viral Hepatitis 2021;28:787
    https://doi.org/10.1111/jvh.13473
  11. Eun-Hee Nah, Yong Jun Choi, Seon Cho, Hyeran Park, Suyoung Kim, Eunjoo Kwon, Han-Ik Cho, Jee-Fu Huang. Changes in nonalcoholic fatty liver disease and M2BPGi due to lifestyle intervention in primary healthcare. PLoS ONE 2024;19:e0298151
    https://doi.org/10.1371/journal.pone.0298151
  12. Nobuharu Tamaki, Masayuki Kurosaki, Yuka Takahashi, Yoshie Itakura, Kento Inada, Sakura Kirino, Koji Yamashita, Shuhei Sekiguchi, Yuka Hayakawa, Leona Osawa, Mayu Higuchi, Kenta Takaura, Chiaki Maeyashiki, Shun Kaneko, Yutaka Yasui, Kaoru Tsuchiya, Hiroyuki Nakanishi, Jun Itakura, Namiki Izumi. Liver fibrosis and fatty liver as independent risk factors for cardiovascular disease. J of Gastro and Hepatol 2021;36:2960
    https://doi.org/10.1111/jgh.15589
  13. Minjeong Nam, Mina Hur, Mikyoung Park, Hanah Kim. Novel Usefulness of Krebs von den Lungen 6 (KL-6) with Hemoglobin and Lactate Dehydrogenase for Assessing Bone Marrow Fibrosis. Diagnostics 2022;12:628
    https://doi.org/10.3390/diagnostics12030628
  14. Kwang Il Seo, Hyunyong Hwang, Byung Cheol Yun, Hyung Hwan Moon, Young Il Choi, Dong Hoon Shin, Myunghee Yoon. A prospective study of the correlation between hepatic fibrosis and noninvasively measured fibrosis markers including serum M2BPGi and acoustic radiation force impulse elastography. KMJ 2022;37:146
    https://doi.org/10.7180/kmj.22.110
  15. Hiroko Shimazaki, Haruki Uojima, Kazumi Yamasaki, Tomomi Obayashi, Sayaka Fuseya, Takashi Sato, Masashi Mizokami, Atsushi Kuno. M2BPgs-HCC: An Automated Multilectin Bead Array Indicating Aberrant Glycosylation Signatures Toward Hepatitis C Virus-Associated Hepatocellular Carcinoma Prognosis. Molecules 2024;29:5640
    https://doi.org/10.3390/molecules29235640
  16. Yiyoung Kwon, Eun Sil Kim, Yon Ho Choe, Mi Jin Kim. Stratification by Non-invasive Biomarkers of Non-alcoholic Fatty Liver Disease in Children. Front. Pediatr. 2022;10
    https://doi.org/10.3389/fped.2022.846273
  17. Xinyu Liu, Wei Zhang, Baofeng Ma, Chunlei Lv, Mimi Sun, Qinghua Shang. The value of serum Mac-2 binding protein glycosylation isomer in the diagnosis of liver fibrosis: a systematic review and meta-analysis. Front. Physiol. 2024;15
    https://doi.org/10.3389/fphys.2024.1382293
  18. Kento Inada, Nobuharu Tamaki, Masayuki Kurosaki, Sakura Kirino, Koji Yamashita, Yuka Hayakawa, Mayu Higuchi, Kenta Takaura, Shun Kaneko, Chiaki Maeyashiki, Yutaka Yasui, Kaoru Tsuchiya, Hiroyuki Nakanishi, Namiki Izumi. Validation of magnetic resonance elastography plus fibrosis‐4 for significant fibrosis in nonalcoholic fatty liver disease. J of Gastro and Hepatol 2022;37:1726
    https://doi.org/10.1111/jgh.15893
  19. Yu‐Ping Chang, Chen‐Hua Liu, Chiuan‐Bo Huang, Ji‐Yuh Lee, Chun‐Jen Liu, Tung‐Hung Su, Shang‐Chin Huang, Tai‐Chung Tseng, Pei‐Jer Chen, Jia‐Horng Kao. Serum Mac‐2 binding protein glycosylation isomer dynamics in patients achieving sustained virologic response for hepatitis C virus. J of Gastro and Hepatol 2024;39:2439
    https://doi.org/10.1111/jgh.16680
  20. Saut Horas H. Nababan, Kemal Fariz Kalista, Chyntia O.M. Jasirwan, Juferdy Kurniawan, Cosmas Rinaldi A. Lesmana, Andri S. Sulaiman, Irsan Hasan, Rino A. Gani. Mac-2 Binding Protein Glycosylation Isomer for Screening High-Risk Esophageal Varices in Liver Cirrhotic Patient. Livers 2021;1:60
    https://doi.org/10.3390/livers1020006
  21. Takako Inoue, Yasuhito Tanaka. Comprehensive Guide to Hepatitis Advances. 2021.
    https://doi.org/10.1016/B978-0-323-98368-6.00009-4
  22. Mohammadjavad Sotoudeheian. Value of Mac-2 Binding Protein Glycosylation Isomer (M2BPGi) in Assessing Liver Fibrosis in Metabolic Dysfunction-Associated Liver Disease: A Comprehensive Review of its Serum Biomarker Role. CPPS 2025;26:6
    https://doi.org/10.2174/0113892037315931240618085529
  23. Pei-Shan Wu, Yun-Cheng Hsieh, Kuei-Chuan Lee, Yi-Hsiang Huang, Ming-Chih Hou, Han-Chieh Lin, Chen-Hua Liu. Mac-2 binding protein glycosylation isomer is a potential biomarker to predict portal hypertension and bacterial infection in cirrhotic patients. PLoS ONE 2021;16:e0258589
    https://doi.org/10.1371/journal.pone.0258589
  24. Chien-Hung Chen. Mac-2 binding protein glycosylation isomer at 5 years of antiviral therapy predict hepatocellular carcinoma and mortality beyond year 5 in chronic hepatitis B patients with cirrhosis. Am J Cancer Res 2024;14:2465
    https://doi.org/10.62347/DAGB7277
  25. Nobuharu Tamaki, Masayuki Kurosaki, Daniel Q. Huang, Rohit Loomba. Noninvasive assessment of liver fibrosis and its clinical significance in nonalcoholic fatty liver disease. Hepatology Research 2022;52:497
    https://doi.org/10.1111/hepr.13764
  26. Siyao Gong, Xin Yu, Qian Li, Ming Chen, Shuguang Yu, Sha Yang. Evaluation of Mac-2 binding protein glycosylation isomer (M2BPGi) as a diagnostic marker for staging liver fibrosis: a meta-analysis. 2024;12:e17611
    https://doi.org/10.7717/peerj.17611
  27. Tyng‐Yuan Jang, Chung‐Feng Huang, Ming‐Lun Yeh, Ching‐I Huang, Chia‐Yen Dai, Pei‐Chien Tsai, Po‐Yau Hsu, Yi‐Ju Wei, Nai‐Jen Hou, Po‐Cheng Liang, Yi‐Hung Lin, Chih‐Wen Wang, Ming‐Yen Hsieh, Zu‐Yau Lin, Jee‐Fu Huang, Ming‐Lung Yu, Wan‐Long Chuang. Serum Wisteria floribunda agglutinin‐positive Mac‐2‐binding protein expression predicts disease severity in nonalcoholic steatohepatitis patients. The Kaohsiung J of Med Scie 2022;38:261
    https://doi.org/10.1002/kjm2.12474
  28. Mayu Higuchi, Nobuharu Tamaki, Masayuki Kurosaki, Kento Inada, Sakura Kirino, Koji Yamashita, Yuka Hayakawa, Leona Osawa, Kenta Takaura, Chiaki Maeyashiki, Shun Kaneko, Yutaka Yasui, Yuka Takahashi, Kaoru Tsuchiya, Hiroyuki Nakanishi, Jun Itakura, Rohit Loomba, Nobuyuki Enomoto, Namiki Izumi. Longitudinal association of magnetic resonance elastography‐associated liver stiffness with complications and mortality. Aliment Pharmacol Ther 2022;55:292
    https://doi.org/10.1111/apt.16745
  29. Nobuharu Tamaki, Kento Imajo, Suzanne R. Sharpton, Jinho Jung, Nancy Sutter, Nobuyoshi Kawamura, Masato Yoneda, Mark A. Valasek, Cynthia Behling, Claude B. Sirlin, Masayuki Kurosaki, Namiki Izumi, Atsushi Nakajima, Rohit Loomba. Two-Step Strategy, FIB-4 Followed by Magnetic Resonance Elastography, for Detecting Advanced Fibrosis in NAFLD. Clinical Gastroenterology and Hepatology 2023;21:380
    https://doi.org/10.1016/j.cgh.2022.01.023
  30. Ming Jian Lian, Zhi Qi Chen, Qian Ming Wang, Gang Sen Zheng, Guo Lin Hong. Diagnostic accuracy of mac‐2‐binding protein glycosylation isomer for diagnosing hepatitis B‐related fibrosis: A meta‐analysis. J of Digest Diseases 2022;23:550
    https://doi.org/10.1111/1751-2980.13140
  31. Hideyuki Tamai, Jumpei Okamura, Takashi Ohoshi, Hisao Wakasaki. Measurements of Serum Mac-2-Binding Protein Glycosylation Isomer and Shear Wave Velocity in Health Checkups Are Useful in Screening for Non-Alcoholic Steatohepatitis. Healthcare 2021;9:523
    https://doi.org/10.3390/healthcare9050523
  32. Jeanne Perpétue Vincent, Gibril Ndow, Shintaro Ogawa, Amie Ceesay, Ramou Njie, Bakary Sanneh, Ignatius Baldeh, Umberto D’Alessandro, Maimuna Mendy, Mark Thursz, Isabelle Chemin, Yasuhito Tanaka, Maud Lemoine, Yusuke Shimakawa. Mac-2 binding protein glycosylation isomer (M2BPGi) to evaluate liver fibrosis and cancer in HBV-infected patients in West Africa. J Glob Health 2022;12
    https://doi.org/10.7189/jogh.12.04076
  33. Nobuharu Tamaki, Masayuki Kurosaki, Yutaka Yasui, Nami Mori, Keiji Tsuji, Chitomi Hasebe, Kouji Joko, Takehiro Akahane, Koichiro Furuta, Haruhiko Kobashi, Hiroyuki Kimura, Hitoshi Yagisawa, Hiroyuki Marusawa, Masahiko Kondo, Yuji Kojima, Hideo Yoshida, Yasushi Uchida, Toshifumi Tada, Shinichiro Nakamura, Satoshi Yasuda, Hidenori Toyoda, Rohit Loomba, Namiki Izumi. Hepatocellular Carcinoma Risk Assessment for Patients With Advanced Fibrosis After Eradication of Hepatitis C Virus. Hepatol Commun 2022;6:461
    https://doi.org/10.1002/hep4.1833
  34. Sakura Kirino, Nobuharu Tamaki, Masayuki Kurosaki, Shun Kaneko, Kento Inada, Yuki Tanaka, Shun Ishido, Koji Yamashita, Tsubasa Nobusawa, Hiroaki Matsumoto, Yuka Hayakawa, Tatsuya Kakegawa, Mayu Higuchi, Kenta Takaura, Shohei Tanaka, Chiaki Maeyashiki, Yutaka Yasui, Yuka Takahashi, Kaoru Tsuchiya, Hiroyuki Nakanishi, Ryuichi Okamoto, Namiki Izumi. Alanine aminotransferase levels as therapeutic targets after nucleotide/nucleoside analog therapy in patient with chronic hepatitis B. Hepatology Research 2023;53:35
    https://doi.org/10.1111/hepr.13839
  35. Mina Hur, Mikyoung Park, Hee-Won Moon, Won Hyeok Choe, Chae Hoon Lee. Comparison of Non-Invasive Clinical Algorithms for Liver Fibrosis in Patients With Chronic Hepatitis B to Reduce the Need for Liver Biopsy: Application of Enhanced Liver Fibrosis and Mac-2 Binding Protein Glycosylation Isomer. Ann Lab Med 2022;42:249
    https://doi.org/10.3343/alm.2022.42.2.249
  36. Yu-Ming Cheng, Chia-Chi Wang. Serum Mac-2 Binding Protein Glycosylation Isomer (M2BPGi) Can Predict Mild or Significant Liver Fibrosis in Non-alcoholic Fatty Liver Disease. Hepat Mon 2021;21
    https://doi.org/10.5812/hepatmon.115400